<!DOCTYPE html>
<html dir="ltr" lang="en" prefix="content: http://purl.org/rss/1.0/modules/content/  dc: http://purl.org/dc/terms/  foaf: http://xmlns.com/foaf/0.1/  og: http://ogp.me/ns#  rdfs: http://www.w3.org/2000/01/rdf-schema#  schema: http://schema.org/  sioc: http://rdfs.org/sioc/ns#  sioct: http://rdfs.org/sioc/types#  skos: http://www.w3.org/2004/02/skos/core#  xsd: http://www.w3.org/2001/XMLSchema# ">
 <head>
  <meta charset="utf-8"/>
  <link href="https://ir.novavax.com/press-releases/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine" rel="canonical"/>
  <meta content="Meet innovative vaccine technology from Novavax. Our biotech company prevents a broad range of infectious diseases through recombinant nanoparticle technology." name="description"/>
  <meta content="Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine" property="og:title"/>
  <meta content="Meet innovative vaccine technology from Novavax. Our biotech company prevents a broad range of infectious diseases through recombinant nanoparticle technology." property="og:description"/>
  <meta content="https://ir.novavax.com/sites/default/files/images/novavax-ir-logo.jpg" property="og:image"/>
  <meta content="summary_large_image" name="twitter:card"/>
  <meta content="Meet innovative vaccine technology from Novavax. Our biotech company prevents a broad range of infectious diseases through recombinant nanoparticle technology." name="twitter:description"/>
  <meta content="Drupal 9 (https://www.drupal.org)" name="Generator"/>
  <meta content="width" name="MobileOptimized"/>
  <meta content="true" name="HandheldFriendly"/>
  <meta content="width=device-width, initial-scale=1, shrink-to-fit=no" name="viewport"/>
  <style>
   div#sliding-popup, div#sliding-popup .eu-cookie-withdraw-banner, .eu-cookie-withdraw-tab {background: #0779bf} div#sliding-popup.eu-cookie-withdraw-wrapper { background: transparent; } #sliding-popup h1, #sliding-popup h2, #sliding-popup h3, #sliding-popup p, #sliding-popup label, #sliding-popup div, .eu-cookie-compliance-more-button, .eu-cookie-compliance-secondary-button, .eu-cookie-withdraw-tab { color: #ffffff;} .eu-cookie-withdraw-tab { border-color: #ffffff;}
  </style>
  <meta content="ie=edge" http-equiv="x-ua-compatible"/>
  <script type="text/javascript">
   (window.NREUM||(NREUM={})).init={ajax:{deny_list:["bam.nr-data.net"]}};(window.NREUM||(NREUM={})).loader_config={licenseKey:"NRJS-791f154b50ffd458658",applicationID:"586088839"};;/*! For license information please see nr-loader-rum-1.236.0.min.js.LICENSE.txt */
(()=>{"use strict";var e,t,n={5763:(e,t,n)=>{n.d(t,{P_:()=>f,Mt:()=>p,C5:()=>s,DL:()=>m,OP:()=>_,lF:()=>E,Yu:()=>y,Dg:()=>g,CX:()=>c,GE:()=>b,sU:()=>j});var r=n(8632),i=n(9567);const o={beacon:r.ce.beacon,errorBeacon:r.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,r.Qy)(e,a[e],"info")}var d=n(7056);const u=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:d.oD,inactiveMs:d.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},l={};function f(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!l[e])throw new Error("Configuration for ".concat(e," was never set"));return l[e]}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");l[e]=(0,i.D)(t,u()),(0,r.Qy)(e,l[e],"config")}function p(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var n=f(e);if(n){for(var r=t.split("."),i=0;i<r.length-1;i++)if("object"!=typeof(n=n[r[i]]))return;n=n[r[r.length-1]]}return n}const h={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},v={};function m(e){if(!e)throw new Error("All loader-config objects require an agent identifier!");if(!v[e])throw new Error("LoaderConfig for ".concat(e," was never set"));return v[e]}function b(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");v[e]=(0,i.D)(t,h),(0,r.Qy)(e,v[e],"loader_config")}const y=(0,r.mF)().o;var w=n(385),A=n(6818);const x={buildEnv:A.Re,bytesSent:{},queryBytesSent:{},customTransaction:void 0,disabled:!1,distMethod:A.gF,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,offset:Math.floor(w._A?.performance?.timeOrigin||w._A?.performance?.timing?.navigationStart||Date.now()),onerror:void 0,origin:""+w._A.location,ptid:void 0,releaseIds:{},session:void 0,xhrWrappable:"function"==typeof w._A.XMLHttpRequest?.prototype?.addEventListener,version:A.q4},D={};function _(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!D[e])throw new Error("Runtime for ".concat(e," was never set"));return D[e]}function j(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");D[e]=(0,i.D)(t,x),(0,r.Qy)(e,D[e],"runtime")}function E(e){return function(e){try{const t=s(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}(e)}},9567:(e,t,n)=>{n.d(t,{D:()=>i});var r=n(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,r.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,r.Z)("Setting a Configurable requires a model to set its initial properties");const n=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(n).length?e:n;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?n[a]=i(e[a],t[a]):n[a]=e[a]}catch(e){(0,r.Z)("An error occurred while setting a property of a Configurable",e)}return n}catch(e){(0,r.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,n)=>{n.d(t,{Re:()=>i,gF:()=>o,q4:()=>r});const r="1.236.0",i="PROD",o="CDN"},385:(e,t,n)=>{n.d(t,{FN:()=>a,IF:()=>d,Nk:()=>l,Tt:()=>s,_A:()=>o,il:()=>r,pL:()=>c,v6:()=>i,w1:()=>u});const r="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=r?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,d=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),u=Boolean(r&&window.document.documentMode),l=!!navigator.sendBeacon},1117:(e,t,n)=>{n.d(t,{w:()=>o});var r=n(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,r.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,n]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=n)}))}catch(e){(0,r.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,n)=>{n.d(t,{L:()=>u,R:()=>c});var r=n(2177),i=n(1284),o=n(4322),a=n(3325);const s={};function c(e,t){const n={staged:!1,priority:a.p[t]||0};d(e),s[e].get(t)||s[e].set(t,n)}function d(e){e&&(s[e]||(s[e]=new Map))}function u(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(d(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const n=[...s[e]];function a(t){const n=e?r.ee.get(e):r.ee,a=o.X.handlers;if(n.backlog&&a){var s=n.backlog[t],c=a[t];if(c){for(var d=0;s&&d<s.length;++d)l(s[d],c);(0,i.D)(c,(function(e,t){(0,i.D)(t,(function(t,n){n[0].on(e,n[1])}))}))}delete a[t],n.backlog[t]=null,n.emit("drain-"+t,[])}}n.every((e=>{let[t,n]=e;return n.staged}))&&(n.sort(((e,t)=>e[1].priority-t[1].priority)),n.forEach((e=>{let[t]=e;a(t)})))}function l(e,t){var n=e[1];(0,i.D)(t[n],(function(t,n){var r=e[0];if(n[0]===r){var i=n[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,n)=>{n.d(t,{ee:()=>d});var r=n(8632),i=n(2210),o=n(1284),a=n(5763),s="nr@context";let c=(0,r.fP)();var d;function u(){}function l(){return new u}function f(){d.aborted=!0,d.backlog={}}c.ee?d=c.ee:(d=function e(t,n){var r={},c={},g={},p=!1;try{p=16===n.length&&(0,a.OP)(n).isolatedBacklog}catch(e){}var h={on:b,addEventListener:b,removeEventListener:y,emit:m,get:A,listeners:w,context:v,buffer:x,abort:f,aborted:!1,isBuffering:D,debugId:n,backlog:p?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return h;function v(e){return e&&e instanceof u?e:e?(0,i.X)(e,s,l):l()}function m(e,n,r,i,o){if(!1!==o&&(o=!0),!d.aborted||i){t&&o&&t.emit(e,n,r);for(var a=v(r),s=w(e),u=s.length,l=0;l<u;l++)s[l].apply(a,n);var f=_()[c[e]];return f&&f.push([h,e,n,a]),a}}function b(e,t){r[e]=w(e).concat(t)}function y(e,t){var n=r[e];if(n)for(var i=0;i<n.length;i++)n[i]===t&&n.splice(i,1)}function w(e){return r[e]||[]}function A(t){return g[t]=g[t]||e(h,t)}function x(e,t){var n=_();h.aborted||(0,o.D)(e,(function(e,r){t=t||"feature",c[r]=t,t in n||(n[t]=[])}))}function D(e){return!!_()[c[e]]}function _(){return h.backlog}}(void 0,"globalEE"),c.ee=d)},5546:(e,t,n)=>{n.d(t,{E:()=>r,p:()=>i});var r=n(2177).ee.get("handle");function i(e,t,n,i,o){o?(o.buffer([e],i),o.emit(e,t,n)):(r.buffer([e],i),r.emit(e,t,n))}},4322:(e,t,n)=>{n.d(t,{X:()=>o});var r=n(5546);o.on=a;var i=o.handlers={};function o(e,t,n,o){a(o||r.E,i,e,t,n)}function a(e,t,n,i,o){o||(o="feature"),e||(e=r.E);var a=t[o]=t[o]||{};(a[n]=a[n]||[]).push([e,i])}},3239:(e,t,n)=>{n.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var r=n(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};r._A.addEventListener("test",null,e),r._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let n=arguments.length>2&&void 0!==arguments[2]&&arguments[2],r=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(n,r))}function c(e,t){let n=arguments.length>2&&void 0!==arguments[2]&&arguments[2],r=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(n,r))}},4402:(e,t,n)=>{n.d(t,{Rl:()=>a,ky:()=>s});var r=n(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=r._A?.crypto||r._A?.msCrypto;let t,n=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++n).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=r._A?.crypto||r._A?.msCrypto;let n,i=0;t&&t.getRandomValues&&(n=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s<e;s++)a.push(o(n,++i).toString(16));return a.join("")}},7056:(e,t,n)=>{n.d(t,{Bq:()=>r,Hb:()=>o,oD:()=>i});const r="NRBA",i=144e5,o=18e5},7894:(e,t,n)=>{function r(){return Math.round(performance.now())}n.d(t,{z:()=>r})},50:(e,t,n)=>{function r(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}n.d(t,{Z:()=>r})},2587:(e,t,n)=>{n.d(t,{N:()=>c,T:()=>d});var r=n(2177),i=n(5546),o=n(8e3),a=n(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const n=r.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,r]=e;void 0===d[t]&&(s[t]?s[t].forEach((e=>{r?(0,i.p)("feat-"+t,[],void 0,e,n):(0,i.p)("block-"+t,[],void 0,e,n),(0,i.p)("rumresp-"+t,[Boolean(r)],void 0,e,n)})):r&&(0,i.p)("feat-"+t,[],void 0,void 0,n),d[t]=Boolean(r))})),Object.keys(s).forEach((e=>{void 0===d[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,n))),d[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const d={}},2210:(e,t,n)=>{n.d(t,{X:()=>i});var r=Object.prototype.hasOwnProperty;function i(e,t,n){if(r.call(e,t))return e[t];var i=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,n)=>{n.d(t,{D:()=>r});const r=(e,t)=>Object.entries(e||{}).map((e=>{let[n,r]=e;return t(n,r)}))},4351:(e,t,n)=>{n.d(t,{P:()=>o});var r=n(2177);const i=()=>{const e=new WeakSet;return(t,n)=>{if("object"==typeof n&&null!==n){if(e.has(n))return;e.add(n)}return n}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{r.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,n)=>{n.d(t,{K:()=>a,b:()=>o});var r=n(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,r.bP)("load",e,t)}function a(e){if(i())return e();(0,r.iz)("DOMContentLoaded",e)}},8632:(e,t,n)=>{n.d(t,{EZ:()=>d,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>u,mF:()=>s});var r=n(7894),i=n(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,n){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,r.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[n]:t}},i}function d(e,t){a()[e]=t}function u(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,n)=>{n.d(t,{N:()=>i});var r=n(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],n=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,r.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),n,i)}},3081:(e,t,n)=>{n.d(t,{gF:()=>o,mY:()=>i,t9:()=>r,vz:()=>s,xS:()=>a});const r=n(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},7633:(e,t,n)=>{n.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>r});const r=n(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,n)=>{n.d(t,{t:()=>r});const r=n(3325).D.pageViewTiming},5938:(e,t,n)=>{n.d(t,{W:()=>o});var r=n(5763),i=n(2177);class o{constructor(e,t,n){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,r.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=n,this.blocked=!1}}},9144:(e,t,n)=>{n.d(t,{j:()=>v});var r=n(3325),i=n(5763),o=n(5546),a=n(2177),s=n(7894),c=n(8e3),d=n(3960),u=n(385),l=n(50),f=n(3081),g=n(8632);function p(){const e=(0,g.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var n=arguments.length,r=new Array(n),i=0;i<n;i++)r[i]=arguments[i];return function(t){for(var n=arguments.length,r=new Array(n>1?n-1:0),i=1;i<n;i++)r[i-1]=arguments[i];let o=[];return Object.values(e.initializedAgents).forEach((e=>{e.exposed&&e.api[t]&&o.push(e.api[t](...r))})),o.length>1?o:o[0]}(t,...r)}}))}var h=n(2587);function v(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},v=arguments.length>2?arguments[2]:void 0,m=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:A={loaderType:v},exposed:x=!0}=t;const D=(0,g.gG)();y||(b=D.init,y=D.info,w=D.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,A),y.jsAttributes??={},u.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),p();const _=function(e,t){t||(0,c.R)(e,"api");const g={};var p=a.ee.get(e),h=p.get("tracer"),v="api-",m=v+"ixn-";function b(t,n,r,o){const a=(0,i.C5)(e);return null===n?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:n}}),A(v,r,!0,o||null===n?"session":void 0)(t,n)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>g[e]=A(v,e,!0,"api"))),g.addPageAction=A(v,"addPageAction",!0,r.D.pageAction),g.setCurrentRouteName=A(v,"routeName",!0,r.D.spa),g.setPageViewName=function(t,n){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(n||"http://custom.transaction")+t,A(v,"setPageViewName",!0)()},g.setCustomAttribute=function(e,t){let n=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",n);(0,l.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of <".concat(typeof t,"> was provided."))}else(0,l.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of <".concat(typeof e,"> was provided."))},g.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,l.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of <".concat(typeof e,"> was provided."))},g.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var n={},i=this,a="function"==typeof t;return(0,o.p)(m+"tracer",[(0,s.z)(),e,n],i,r.D.spa,p),function(){if(h.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],n),a)try{return t.apply(this,arguments)}catch(e){throw h.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],n),e}finally{h.emit("fn-end",[(0,s.z)()],n)}}}};function A(e,t,n,i){return function(){return(0,o.p)(f.xS,["API/"+t+"/called"],void 0,r.D.metrics,p),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],n?null:this,i,p),n?void 0:this}}function x(){n.e(439).then(n.bind(n,7438)).then((t=>{let{setAPI:n}=t;n(e),(0,c.L)(e,"api")})).catch((()=>(0,l.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=A(m,e,void 0,r.D.spa)})),g.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(f.xS,["API/noticeError/called"],void 0,r.D.metrics,p),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,r.D.jserrors,p)},u.il?(0,d.b)((()=>x()),!0):x(),g}(e,m);return(0,g.Qy)(e,_,"api"),(0,g.Qy)(e,x,"exposed"),(0,g.EZ)("activatedFeatures",h.T),_}},3325:(e,t,n)=>{n.d(t,{D:()=>r,p:()=>i});const r={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[r.pageViewEvent]:1,[r.pageViewTiming]:2,[r.metrics]:3,[r.jserrors]:4,[r.ajax]:5,[r.sessionTrace]:6,[r.pageAction]:7,[r.spa]:8,[r.sessionReplay]:9}}},r={};function i(e){var t=r[e];if(void 0!==t)return t.exports;var o=r[e]={exports:{}};return n[e](o,o.exports,i),o.exports}i.m=n,i.d=(e,t)=>{for(var n in t)i.o(t,n)&&!i.o(e,n)&&Object.defineProperty(e,n,{enumerable:!0,get:t[n]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,n)=>(i.f[n](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(n,r,o,a)=>{if(e[n])e[n].push(r);else{var s,c;if(void 0!==o)for(var d=document.getElementsByTagName("script"),u=0;u<d.length;u++){var l=d[u];if(l.getAttribute("src")==n||l.getAttribute("data-webpack")==t+o){s=l;break}}s||(c=!0,(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=n),e[n]=[r];var f=(t,r)=>{s.onerror=s.onload=null,clearTimeout(g);var i=e[n];if(delete e[n],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(r))),t)return t(r)},g=setTimeout(f.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=f.bind(null,s.onerror),s.onload=f.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=6,i.p="https://js-agent.newrelic.com/",(()=>{var e={6:0,352:0};i.f.j=(t,n)=>{var r=i.o(e,t)?e[t]:void 0;if(0!==r)if(r)n.push(r[2]);else{var o=new Promise(((n,i)=>r=e[t]=[n,i]));n.push(r[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(n=>{if(i.o(e,t)&&(0!==(r=e[t])&&(e[t]=void 0),r)){var o=n&&("load"===n.type?"missing":n.type),a=n&&n.target&&n.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,r[1](s)}}),"chunk-"+t,t)}};var t=(t,n)=>{var r,o,[a,s,c]=n,d=0;if(a.some((t=>0!==e[t]))){for(r in s)i.o(s,r)&&(i.m[r]=s[r]);if(c)c(i)}for(t&&t(n);d<a.length;d++)o=a[d],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},n=window.webpackChunkNRBA=window.webpackChunkNRBA||[];n.forEach(t.bind(null,0)),n.push=t.bind(null,n.push.bind(n))})();var o={};(()=>{i.r(o);var e=i(3325),t=i(5763);const n=Object.values(e.D);function r(e){const r={};return n.forEach((n=>{r[n]=function(e,n){return!1!==(0,t.Mt)(n,"".concat(e,".enabled"))}(n,e)})),r}var a=i(9144);var s=i(5546),c=i(385),d=i(8e3),u=i(5938),l=i(3960),f=i(50);class g extends u.W{constructor(e,t,n){let r=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,n),this.auto=r,this.abortHandler,this.featAggregate,this.onAggregateImported,r&&(0,d.R)(e,n)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const n=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let r;this.onAggregateImported=new Promise((e=>{r=e}));const o=async()=>{let t;try{if(n){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,f.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,d.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:n}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await n(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),r(!0)}catch(e){(0,f.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),r(!1)}};c.il?(0,l.b)((()=>o()),!0):o()}shouldImportAgg(n,r){return n!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!r?.isNew||!!r?.state.sessionReplay)}}var p=i(7633),h=i(7894);class v extends g{static featureName=p.t9;constructor(n,r){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(n,r,p.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const r=(0,t.OP)(n);r[p.Dz]=Math.max(Date.now()-r.offset,0),(0,l.K)((()=>r[p.qw]=Math.max((0,h.z)()-r[p.Dz],0))),(0,l.b)((()=>{const t=(0,h.z)();r[p.OJ]=Math.max(t-r[p.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var m=i(1117),b=i(1284);class y extends m.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,n,r,i){var o=this.getBucket(e,t,n,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,n){t[e]=w(n,t[e])})),t}(r,o.metrics),o}merge(e,t,n,r,i){var o=this.getBucket(e,t,r,i);if(o.metrics){var a=o.metrics;a.count+=n.count,(0,b.D)(n,(function(e,t){if("count"!==e){var r=a[e],i=n[e];i&&!i.c?a[e]=w(i.t,r):a[e]=function(e,t){if(!t)return e;t.c||(t=A(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=n}storeMetric(e,t,n,r){var i=this.getBucket(e,t,n);return i.stats=w(r,i.stats),i}getBucket(e,t,n,r){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:n||{}},r&&(i.custom=r)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},n="",r=!1,i=0;i<e.length;i++)t[n=e[i]]=x(this.aggregatedData[n]),t[n].length&&(r=!0),delete this.aggregatedData[n];return r?t:null}}function w(e,t){return null==e?function(e){e?e.c++:e={c:1};return e}(t):t?(t.c||(t=A(t.t)),t.c+=1,t.t+=e,t.sos+=e*e,e>t.max&&(t.max=e),e<t.min&&(t.min=e),t):{t:e}}function A(e){return{t:e,min:e,max:e,sos:e*e,c:1}}function x(e){return"object"!=typeof e?[]:(0,b.D)(e,D)}function D(e,t){return t}var _=i(8632),j=i(4402),E=i(4351);var k=i(7956),T=i(3239),I=i(9251);class N extends g{static featureName=I.t;constructor(e,n){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,n,I.t,r),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,k.N)((()=>(0,s.p)("docHidden",[(0,h.z)()],void 0,I.t,this.ee)),!0),(0,T.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,h.z)()],void 0,I.t,this.ee))),this.importAggregator())}}var P=i(3081);class S extends g{static featureName=P.t9;constructor(e,t){let n=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,n),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,j.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(v),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,f.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const n=r(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,n)=>e.p[t.featureName]-e.p[n.featureName])),i.forEach((t=>{if(n[t.featureName]||t.featureName===e.D.pageViewEvent){const r=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);r.every((e=>n[e]))||(0,f.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,E.P)(r),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,_.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,f.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const n=(0,_.fP)();return delete n.initializedAgents[this.agentIdentifier]?.api,delete n.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,n.ee?.abort(),delete n.ee?.get(this.agentIdentifier),!1}}}({features:[v,N,S],loaderType:"lite"})})(),window.NRBA=o})();
  </script>
  <link href="/sites/default/files/Nvax_favicon_32x32.png" rel="icon" type="image/png"/>
  <title>
   Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
  </title>
  <!-- Google Tag Manager -->
  <script>
   (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-NXGSZ8G');
  </script>
  <!-- End Google Tag Manager -->
  <link href="https://use.typekit.net/bjz3zry.css" rel="stylesheet"/>
  <link href="/sites/default/files/css/css_pdnWchZC6RVnn-T2vV_LIX9yGkYKL1U9CbSrkAvTRwI.css" media="all" rel="stylesheet">
   <link href="/sites/default/files/css/css_UF_GXYIZ9Z69n26Nhau8NWpjLFaKlyKYjdV3-E2VoPM.css" media="all" rel="stylesheet"/>
   <link href="https://api.mapbox.com/mapbox-gl-js/v2.6.1/mapbox-gl.css" media="all" rel="stylesheet"/>
   <link href="/sites/default/files/css/css_OzkZEM2G-UFn6w2zdbKRK63hM8VxqLtOe5vcQZJC2cM.css" media="all" rel="stylesheet"/>
  </link>
 </head>
 <body class="layout-no-sidebars user-anonymous path-press-releases">
  <!-- Google Tag Manager (noscript) -->
  <noscript>
   <iframe height="0" src="https://www.googletagmanager.com/ns.html?id=GTM-NXGSZ8G" style="display:none;visibility:hidden" width="0">
   </iframe>
  </noscript>
  <!-- End Google Tag Manager (noscript) -->
  <a class="visually-hidden focusable skip-link" href="#main-content">
   Skip to main content
  </a>
  <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas="">
   <div id="page-wrapper">
    <div id="page">
     <div class="highlighted">
      <aside class="container section clearfix" role="complementary">
       <div class="hidden" data-drupal-messages-fallback="">
       </div>
      </aside>
     </div>
     <div class="layout-main-wrapper clearfix" id="main-wrapper">
      <div class="container" id="main">
       <div class="row row-offcanvas row-offcanvas-left clearfix">
        <main class="main-content col order-last" id="content" role="main">
         <section class="section">
          <a id="main-content" tabindex="-1">
          </a>
          <style>
           .edit__action{padding: 0 5px;}
          </style>
          <div class="block block-system block-system-main-block" id="block-nvaxcom-bootstrap-content">
           <div class="content">
            <div class="act-panel layout layout--panel-container layout--pressdetailpage pressDetailPage">
             <div class="act-layout act-pane layout layout--bs-columns layout--header-section -rgnWidth100">
              <div class="section-inner">
               <div class="act-pane__content row">
                <div class="act-pane__region layout__region layout__region--col-1 col-lg-12 col-md-12 col-sm-12">
                 <div class="oc-header act-component">
                  <div aria-label="Primary" class="oc-header__rgnInner act-component-inner" role="navigation">
                   <div class="oc-header__rgnDesktop d-none d-lg-flex">
                    <div class="oc-header__rgnMain">
                     <ul class="oc-header__rgnMegaNav">
                      <li class="oc-header__megaItem nav-item dropdown position-static">
                       <a aria-expanded="false" aria-haspopup="true" class="oc-header__megaLink nav-link dropdown-toggle menu-down" data-toggle="dropdown" href="#" id="i8oo6Y">
                        Science &amp; technology
                       </a>
                       <div aria-labelledby="i8oo6Y" class="oc-header__megaPane dropdown-menu w-100">
                        <div class="oc-mmPane act-component">
                         <div class="oc-mmPane__rgnInner act-component-inner">
                          <div class="oc-mmPane__rgnIntro">
                           <div class="oc-mmPane__title">
                            <div class="af-text">
                             Science &amp; technology
                            </div>
                           </div>
                           <div class="oc-mmPane__body">
                            <div class="af-text">
                             <p>
                              Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
                             </p>
                            </div>
                           </div>
                          </div>
                          <ul class="oc-mmPane__rgnNav">
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Overview" class="af-link" href="https://www.novavax.com/science-technology">
                             Overview
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Our pipeline" class="af-link" href="https://www.novavax.com/science-technology/vaccine-pipeline">
                             Our pipeline
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Matrix-M™ adjuvant" class="af-link" href="https://www.novavax.com/science-technology/matrix-m-adjuvant-technology">
                             Matrix-M™ adjuvant
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Recombinant, protein-based nanoparticle vaccine" class="af-link" href="https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology">
                             Recombinant, protein-based nanoparticle vaccine
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Global vaccine approval/authorization map" class="af-link" href="https://www.novavax.com/global-vaccine-approval-authorization-map">
                             Global vaccine approval/authorization map
                            </a>
                           </li>
                          </ul>
                          <div class="oc-mmPane__rgnPromo">
                           <div class="oc-mmPane__promoImage">
                            <img alt="" class="af-image" src="/sites/default/files/images/Main%20Nav%20Science_0.png"/>
                           </div>
                           <div class="oc-mmPane__promoTitle">
                            <div class="af-text">
                             COVID-19 UPDATES
                            </div>
                           </div>
                           <div class="oc-mmPane__promoBody">
                            <div class="af-text">
                             <p>
                              Novavax has demonstrated its ability to quickly develop viable vaccine candidates for emerging infectious diseases such as COVID-19.
                             </p>
                            </div>
                           </div>
                           <div class="oc-mmPane__promoLink">
                            <a aria-label="Learn more about our COVID-19 updates" class="af-link" href="https://www.novavax.com/covid-19-press-releases">
                             Learn more about our COVID-19 updates
                            </a>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </li>
                      <li class="oc-header__megaItem nav-item dropdown position-static">
                       <a aria-expanded="false" aria-haspopup="true" class="oc-header__megaLink nav-link dropdown-toggle menu-down" data-toggle="dropdown" href="#" id="jRaUvh">
                        Who we are
                       </a>
                       <div aria-labelledby="jRaUvh" class="oc-header__megaPane dropdown-menu w-100">
                        <div class="oc-mmPane act-component">
                         <div class="oc-mmPane__rgnInner act-component-inner">
                          <div class="oc-mmPane__rgnIntro">
                           <div class="oc-mmPane__title">
                            <div class="af-text">
                             Who we are
                            </div>
                           </div>
                           <div class="oc-mmPane__body">
                            <div class="af-text">
                             <p>
                              We are a biotechnology company committed to help address serious infectious disease globally through the discovery and development of innovative vaccines to patients around the world.
                             </p>
                            </div>
                           </div>
                          </div>
                          <ul class="oc-mmPane__rgnNav">
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Our company" class="af-link" href="https://www.novavax.com/who-we-are">
                             Our company
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Our team" class="af-link" href="https://www.novavax.com/who-we-are/leadership#executive-leadership">
                             Our team
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Our partners" class="af-link" href="https://www.novavax.com/who-we-are/partners">
                             Our partners
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Our commitments" class="af-link" href="https://www.novavax.com/who-we-are/our-commitments">
                             Our commitments
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Our transparency commitment" class="af-link" href="https://www.novavax.com/who-we-are/global-disclosure-statement">
                             Our transparency commitment
                            </a>
                           </li>
                          </ul>
                          <div class="oc-mmPane__rgnPromo">
                           <div class="oc-mmPane__promoImage">
                            <img alt="" class="af-image" src="/sites/default/files/images/Main%20Nav%20Who.png"/>
                           </div>
                           <div class="oc-mmPane__promoTitle">
                            <div class="af-text">
                             Build your future with us
                            </div>
                           </div>
                           <div class="oc-mmPane__promoBody">
                            <div class="af-text">
                             <p>
                              Join other passionately curious people who are bringing innovative vaccines to the world
                             </p>
                            </div>
                           </div>
                           <div class="oc-mmPane__promoLink">
                            <a aria-label="Discover career opportunities" class="af-link" href="https://www.novavax.com/careers">
                             Discover career opportunities
                            </a>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </li>
                      <li class="oc-header__megaItem nav-item dropdown position-static">
                       <a aria-expanded="false" aria-haspopup="true" class="oc-header__megaLink nav-link dropdown-toggle menu-down" data-toggle="dropdown" href="#" id="yuPhSZ">
                        Insights
                       </a>
                       <div aria-labelledby="yuPhSZ" class="oc-header__megaPane dropdown-menu w-100">
                        <div class="oc-mmPane act-component -noPromo">
                         <div class="oc-mmPane__rgnInner act-component-inner">
                          <div class="oc-mmPane__rgnIntro">
                           <div class="oc-mmPane__title">
                            <div class="af-text">
                             Insights
                            </div>
                           </div>
                           <div class="oc-mmPane__body">
                            <div class="af-text">
                             <p>
                              Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
                             </p>
                            </div>
                           </div>
                          </div>
                          <ul class="oc-mmPane__rgnNav">
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Articles" class="af-link" href="https://www.novavax.com/insights-articles">
                             Articles
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Diversity matters: Inclusivity in clinical trials" class="af-link" href="https://www.novavax.com/insights/diversity-matters-inclusivity-clinical-trials">
                             Diversity matters: Inclusivity in clinical trials
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="From pandemic to endemic: Why COVID-19 may be here to stay" class="af-link" href="https://www.novavax.com/insights/pandemic-endemic-why-covid-19-may-be-here-stay">
                             From pandemic to endemic: Why COVID-19 may be here to stay
                            </a>
                           </li>
                           <li class="oc-mmPane__navLink">
                            <a aria-label="Standing on the shoulders of giants: How a Novavax vaccine is developed" class="af-link" href="https://www.novavax.com/insights/how-novavax-vaccine-developed">
                             Standing on the shoulders of giants: How a Novavax vaccine is developed
                            </a>
                           </li>
                          </ul>
                         </div>
                        </div>
                       </div>
                      </li>
                     </ul>
                     <div class="oc-header__rgnLogo">
                      <a href="https://www.novavax.com">
                       <div class="oc-header__logo">
                        <img alt="Novavax" class="af-image" src="/sites/default/files/images/novavax-header-logo.svg"/>
                       </div>
                      </a>
                     </div>
                     <ul class="oc-header__rgnLinkNav">
                      <li class="oc-header__linkItem">
                       <div class="oc-header__menuLink">
                        <a aria-label="Medical professionals  " class="af-link" href="https://medical.novavax.com/hcp-hub">
                         Medical professionals
                        </a>
                       </div>
                      </li>
                      <li class="oc-header__linkItem">
                       <div class="oc-header__menuLink">
                        <a aria-label="News &amp; media" class="af-link" href="https://www.novavax.com/news-and-media">
                         News &amp; media
                        </a>
                       </div>
                      </li>
                      <li class="oc-header__linkItem">
                       <div class="oc-header__menuLink">
                        <a aria-label="Investors" class="af-link" href="https://ir.novavax.com">
                         Investors
                        </a>
                       </div>
                      </li>
                      <li class="oc-header__linkItem">
                       <div class="oc-header__menuLink">
                        <a aria-label="Careers" class="af-link" href="https://www.novavax.com/careers">
                         Careers
                        </a>
                       </div>
                      </li>
                     </ul>
                    </div>
                   </div>
                   <div class="oc-header__rgnDevice d-flex d-lg-none">
                    <nav class="navbar navbar-collapse">
                     <div class="navbar-brand oc-header__rgnLogo">
                      <a href="https://www.novavax.com">
                       <div class="oc-header__logo">
                        <img alt="Novavax" class="af-image" src="/sites/default/files/images/novavax-header-logo.svg"/>
                       </div>
                      </a>
                     </div>
                     <!-- hamburger icon -->
                     <button aria-controls="mobileMenu" aria-expanded="false" aria-label="Toggle navigation" class="navbar-toggler" data-target="#mobileMenu" data-toggle="collapse" type="button">
                      <span class="navbar-toggler-icon">
                       <i class="fas fa-bars menu-open">
                       </i>
                       <i class="fas fa-times menu-close">
                       </i>
                      </span>
                     </button>
                     <!-- menu -->
                     <div class="collapse navbar-collapse" id="mobileMenu">
                      <div class="navbar-container">
                       <div class="oc-header__rgnMobileMenu">
                        <div class="oc-header__rgnMMTop">
                         <ul class="oc-header__rgnMobileDropNav" id="fODspa">
                          <li class="oc-header__dropMenu">
                           <div class="oc-header__menuParent">
                            <a aria-controls="ux1wuo" aria-expanded="false" class="oc-header__dropTrigger" data-target="#ux1wuo" data-toggle="collapse" href="#" id="si3OEJ">
                             Science &amp; technology
                            </a>
                           </div>
                           <div aria-labelledby="si3OEJ" class="oc-header__menuChild collapse" data-parent="#fODspa" id="ux1wuo">
                            <ul class="oc-header__menuChildInner">
                             <li class="oc-header__childItem">
                              <a aria-label="Overview" class="af-link" href="https://www.novavax.com/science-technology">
                               Overview
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Our pipeline" class="af-link" href="https://www.novavax.com/science-technology/vaccine-pipeline">
                               Our pipeline
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Matrix-M™ adjuvant" class="af-link" href="https://www.novavax.com/science-technology/matrix-m-adjuvant-technology">
                               Matrix-M™ adjuvant
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Recombinant, protein-based nanoparticle vaccine" class="af-link" href="https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology">
                               Recombinant, protein-based nanoparticle vaccine
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Global vaccine approval/authorization map" class="af-link" href="https://www.novavax.com/global-vaccine-approval-authorization-map">
                               Global vaccine approval/authorization map
                              </a>
                             </li>
                            </ul>
                           </div>
                          </li>
                          <li class="oc-header__dropMenu">
                           <div class="oc-header__menuParent">
                            <a aria-controls="ldhvtW" aria-expanded="false" class="oc-header__dropTrigger" data-target="#ldhvtW" data-toggle="collapse" href="#" id="wCqazV">
                             Who we are
                            </a>
                           </div>
                           <div aria-labelledby="wCqazV" class="oc-header__menuChild collapse" data-parent="#fODspa" id="ldhvtW">
                            <ul class="oc-header__menuChildInner">
                             <li class="oc-header__childItem">
                              <a aria-label="Our company" class="af-link" href="https://www.novavax.com/who-we-are">
                               Our company
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Our team" class="af-link" href="https://www.novavax.com/who-we-are/leadership#executive-leadership">
                               Our team
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Our partners" class="af-link" href="https://www.novavax.com/who-we-are/partners">
                               Our partners
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Our commitments" class="af-link" href="https://www.novavax.com/who-we-are/our-commitments">
                               Our commitments
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Our transparency commitment" class="af-link" href="https://www.novavax.com/who-we-are/global-disclosure-statement">
                               Our transparency commitment
                              </a>
                             </li>
                            </ul>
                           </div>
                          </li>
                          <li class="oc-header__dropMenu">
                           <div class="oc-header__menuParent">
                            <a aria-controls="bNTnyF" aria-expanded="false" class="oc-header__dropTrigger" data-target="#bNTnyF" data-toggle="collapse" href="#" id="p5aCAm">
                             Insights
                            </a>
                           </div>
                           <div aria-labelledby="p5aCAm" class="oc-header__menuChild collapse" data-parent="#fODspa" id="bNTnyF">
                            <ul class="oc-header__menuChildInner">
                             <li class="oc-header__childItem">
                              <a aria-label="Articles" class="af-link" href="https://www.novavax.com/insights-articles">
                               Articles
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Diversity matters: Inclusivity in clinical trials" class="af-link" href="https://www.novavax.com/insights/diversity-matters-inclusivity-clinical-trials">
                               Diversity matters: Inclusivity in clinical trials
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="From pandemic to endemic: Why COVID-19 may be here to stay" class="af-link" href="https://www.novavax.com/insights/pandemic-endemic-why-covid-19-may-be-here-stay">
                               From pandemic to endemic: Why COVID-19 may be here to stay
                              </a>
                             </li>
                             <li class="oc-header__childItem">
                              <a aria-label="Standing on the shoulders of giants: How a Novavax vaccine is developed" class="af-link" href="https://www.novavax.com/insights/how-novavax-vaccine-developed">
                               Standing on the shoulders of giants: How a Novavax vaccine is developed
                              </a>
                             </li>
                            </ul>
                           </div>
                          </li>
                         </ul>
                        </div>
                        <div class="oc-header__rgnMMBottom">
                         <ul class="oc-header__rgnMobileLinkNav">
                          <li class="oc-header__menuItem">
                           <a aria-label="Medical professionals  " class="af-link" href="https://medical.novavax.com/hcp-hub">
                            Medical professionals
                           </a>
                          </li>
                          <li class="oc-header__menuItem">
                           <a aria-label="News &amp; media" class="af-link" href="https://www.novavax.com/news-and-media">
                            News &amp; media
                           </a>
                          </li>
                          <li class="oc-header__menuItem">
                           <a aria-label="Investors" class="af-link" href="https://ir.novavax.com">
                            Investors
                           </a>
                          </li>
                          <li class="oc-header__menuItem">
                           <a aria-label="Careers" class="af-link" href="https://www.novavax.com/careers">
                            Careers
                           </a>
                          </li>
                         </ul>
                        </div>
                       </div>
                      </div>
                     </div>
                    </nav>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
              </div>
             </div>
             <div class="act-layout act-pane layout layout--bs-columns layout--main-section -rgnWidth100">
              <div class="section-inner">
               <div class="act-pane__content row">
                <div class="act-pane__region layout__region layout__region--col-1 col-lg-12 col-md-12 col-sm-12">
                 <div class="tpl-detail act-component">
                  <div class="tpl-detail__rgnInner act-component-inner">
                   <div class="tpl-detail__rgnHero">
                    <div class="mc-heroPane act-component -heroSmall">
                     <div class="mc-heroPane__rgnInner act-component-inner">
                      <div class="mc-heroPane__rgnMain" style="background-image: linear-gradient(180deg, rgba(16,24,85,0.7) 30%, rgba(16,24,85,0) 100%), linear-gradient(180deg, rgba(237,237,237,0) 60%, #EDEDED 100%), url(/act-root/novavax/assets/images/banner-pr.png);">
                      </div>
                     </div>
                    </div>
                   </div>
                   <div class="tpl-detail__rgnMain">
                    <div class="oc-pressDetail act-component">
                     <div class="oc-pressDetail__rgnInner act-component-inner">
                      <div class="oc-pressDetail__rgnHeader">
                       <div class="ac-breadcrumb act-component">
                        <div class="ac-breadcrumb__rgnInner act-component-inner">
                         <div aria-current="page" class="ac-breadcrumb__title">
                          <div class="af-text">
                           NEWS &amp; MEDIA
                          </div>
                         </div>
                        </div>
                       </div>
                       <h1 class="oc-pressDetail__title">
                        <div class="af-text">
                         Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
                        </div>
                       </h1>
                      </div>
                      <div class="oc-pressDetail__rgnMain">
                       <div class="oc-pressDetail__date">
                        <div class="af-text">
                         January 31, 2022
                        </div>
                       </div>
                       <div class="oc-pressDetail__body">
                        <div class="af-text">
                         <style type="text/css">
                          /* Style Definitions */
span.prnews_span
{
font-size:8pt;
font-family:"Arial";
color:black;
}
a.prnews_a
{
color:blue;
}
li.prnews_li
{
font-size:8pt;
font-family:"Arial";
color:black;
}
p.prnews_p
{
font-size:0.62em;
font-family:"Arial";
color:black;
margin:0in;
}
                         </style>
                         <p>
                          -
                          <i>
                           NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains
                          </i>
                         </p>
                         <p>
                          <span class="xn-location">
                           GAITHERSBURG, Md.
                          </span>
                          ,
                          <span class="xn-chron">
                           Jan. 31, 2022
                          </span>
                          /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it has submitted a request to the U.S Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) for NVX-CoV2373, its protein-based COVID-19 vaccine candidate for immunization of individuals 18 year of age and older against SARS-CoV-2.
                         </p>
                         <p>
                          The request for EUA is based on the totality of pre-clinical, clinical and manufacturing-related (CMC) data provided to the agency, including results of two large pivotal clinical trials that demonstrated an overall efficacy of approximately 90 percent and a reassuring safety profile.
                         </p>
                         <p>
                          "We're extremely proud of the work of our teams and we look forward to FDA's review of our EUA request. We believe our vaccine offers a differentiated option built on a well-understood protein-based vaccine platform that can be an alternative to the portfolio of available vaccines to help fight the COVID-19 pandemic," said
                          <span class="xn-person">
                           Stanley C. Erck
                          </span>
                          , President and Chief Executive Officer, Novavax. "I'd like to also extend our thanks for the support of the U.S. Department of Health and Human Services and the U.S. Department of Defense for their partnership leading up to today's milestone of EUA request submission."
                         </p>
                         <p>
                          Novavax conducted two pivotal Phase 3 clinical trials: PREVENT-19 which enrolled approximately 30,000 participants in the U.S. and
                          <span class="xn-location">
                           Mexico
                          </span>
                          and published results in the
                          <i>
                           <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=4185830657&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2116185%3Fquery%3Dfeatured_home&amp;a=New+England+Journal+of+Medicine" rel="nofollow" target="_blank">
                            New England Journal of Medicine
                           </a>
                           (NEJM)
                          </i>
                          and a trial with almost 15,000 participants in the U.K. which was also published in
                          <i>
                           <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=889537351&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2107659&amp;a=NEJM" rel="nofollow" target="_blank">
                            NEJM
                           </a>
                          </i>
                          <i>
                           .
                          </i>
                          In both trials, the vaccine demonstrated efficacy with a reassuring safety profile. Serious and severe adverse events were low in number and balanced between vaccine and placebo groups. The most common adverse reactions observed during clinical studies (frequency category of very common ≥1/10) were headache, nausea or vomiting, myalgia, arthralgia, injection site tenderness/pain, fatigue, and malaise. Novavax will continue to collect and analyze real-world data, including the monitoring of safety and the evaluation of variants, as the vaccine is distributed in authorized markets. As part of the PREVENT-19 trial, a booster study is ongoing to evaluate the safety and effectiveness of a third does of the vaccine, as well as a study in adolescents aged 12-17.
                         </p>
                         <p>
                          NVX-CoV2373 has been granted conditional authorization by multiple regulatory agencies worldwide, including the European Commission, and emergency use listing (EUL) from the
                          <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=1252681756&amp;u=https%3A%2F%2Fir.novavax.com%2F2021-12-20-World-Health-Organization-Grants-Second-Emergency-Use-Listing-for-Novavax-COVID-19-Vaccine&amp;a=World+Health+Organization" rel="nofollow" target="_blank">
                           World Health Organization
                          </a>
                          (WHO), with additional filings currently under review.
                         </p>
                         <p>
                          <b>
                           About NVX-CoV2373
                           <br/>
                          </b>
                          NVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease. NVX-CoV2373 was created using Novavax' recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein and is formulated with Novavax' patented saponin-based Matrix-M™ adjuvant to enhance the immune response and stimulate high levels of neutralizing antibodies. NVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
                         </p>
                         <p>
                          Novavax' COVID-19 vaccine is packaged as a ready-to-use liquid formulation in a vial containing ten doses. The vaccination regimen calls for two 0.5 ml doses (5 mcg antigen and 50 mcg Matrix-M adjuvant) given intramuscularly 21 days apart. The vaccine is stored at 2°- 8° Celsius, enabling the use of existing vaccine supply and cold chain channels. Use of the vaccine should be in accordance with official recommendations.
                         </p>
                         <p>
                          Novavax has established partnerships for the manufacture, commercialization and distribution of NVX-CoV2373 worldwide. Existing authorizations leverage Novavax' manufacturing partnership with Serum Institute of
                          <span class="xn-location">
                           India
                          </span>
                          (SII), the world's largest vaccine manufacturer by volume. They will later be supplemented with data from additional manufacturing sites throughout Novavax' global supply chain.
                         </p>
                         <p>
                          <b>
                           About the NVX-CoV2373 Phase 3 trials
                           <br/>
                          </b>
                          NVX-CoV2373 is being evaluated in two pivotal Phase 3 trials.
                         </p>
                         <p>
                          PREVENT-19, a trial in the U.S. and
                          <span class="xn-location">
                           Mexico
                          </span>
                          that enrolled almost 30,000 participants, achieved 90.4% efficacy overall. It was designed as a 2:1 randomized, placebo-controlled, observer-blinded study to evaluate the efficacy, safety and immunogenicity of NVX-CoV2373. The primary endpoint for PREVENT-19 was the first occurrence of PCR-confirmed symptomatic (mild, moderate or severe) COVID-19 with onset at least 7 days after the second dose in serologically negative (to SARS-CoV-2) adult participants at baseline. The statistical success criterion included a lower bound of 95% CI &gt;30%. The key secondary endpoint is the prevention of PCR-confirmed, symptomatic moderate or severe COVID-19. Both endpoints were assessed at least seven days after the second study vaccination in volunteers who had not been previously infected with SARS-CoV-2. It was generally well-tolerated and elicited a robust antibody response after the second dose in both studies. Full results of the trial were published in the
                          <i>
                           <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=4185830657&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2116185%3Fquery%3Dfeatured_home&amp;a=New+England+Journal+of+Medicine" rel="nofollow" target="_blank">
                            New England Journal of Medicine
                           </a>
                          </i>
                          <i>
                           (NEJM).
                          </i>
                         </p>
                         <p>
                          A trial conducted in the U.K. with 14,039 participants was designed as a randomized, placebo-controlled, observer-blinded study and achieved overall efficacy of 89.7%. The primary endpoint was based on the first occurrence of PCR-confirmed symptomatic (mild, moderate or severe) COVID-19 with onset at least 7 days after the second study vaccination in serologically negative (to SARS-CoV-2) adult participants at baseline. Full results of the trial were published in
                          <i>
                           <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=889537351&amp;u=https%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2107659&amp;a=NEJM" rel="nofollow" target="_blank">
                            NEJM
                           </a>
                          </i>
                          .
                         </p>
                         <p>
                          PREVENT-19 is being conducted with support from the U.S. government, including the Department of Defense, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) at HHS. BARDA is providing up to $1.75 billion under a Department of Defense agreement.
                         </p>
                         <p>
                          <b>
                           About Matrix-M™ Adjuvant
                           <br/>
                          </b>
                          Novavax' patented saponin-based Matrix-M™ adjuvant has demonstrated a potent and generally well-tolerated effect by stimulating the entry of antigen-presenting cells into the injection site and enhancing antigen presentation in local lymph nodes, boosting immune response.
                         </p>
                         <p>
                          <b>
                           About Novavax
                           <br/>
                          </b>
                          Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company's proprietary recombinant technology platform harnesses the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles designed to address urgent global health needs. NVX-CoV2373, the company's COVID-19 vaccine, received Conditional Marketing Authorization from the European Commission, Emergency Use Listing from the World Health Organization, Emergency Use Authorization in Indonesia and the
                          <span class="xn-location">
                           Philippines
                          </span>
                          , and has been submitted for regulatory authorization in multiple markets globally.
                         </p>
                         <p>
                          For more information, visit
                          <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=274133259&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3425721-1%26h%3D1328944201%26u%3Dhttp%253A%252F%252Fwww.novavax.com%252F%26a%3Dwww.novavax.com&amp;a=www.novavax.com" rel="nofollow" target="_blank">
                           www.novavax.com
                          </a>
                          and connect with us
                          <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=2646657515&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3425721-1%26h%3D1749870132%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fnovavax%252F%26a%3DLinkedIn&amp;a=LinkedIn" rel="nofollow" target="_blank">
                           LinkedIn
                          </a>
                          .
                         </p>
                         <p>
                          <b>
                           Forward-Looking Statements
                           <br/>
                          </b>
                          Statements herein relating to the future of Novavax, its operating plans and prospects, its partnerships, the ongoing development of NVX-CoV2373, the scope, timing and outcome of future regulatory filings and actions, including Novavax' plans to supplement authorizations with data from the additional manufacturing sites in Novavax' global supply chain, the potential impact of Novavax and NVX-CoV2373 in addressing vaccine access, offering an alternative to existing COVID-19 vaccines, controlling the pandemic and protecting populations, and the efficacy, safety and intended utilization of NVX-CoV2373 are forward-looking statements. Novavax cautions that these forward-looking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include challenges satisfying, alone or together with partners, various safety, efficacy, and product characterization requirements, including those related to process qualification and assay validation, necessary to satisfy applicable regulatory authorities; difficulty obtaining scarce raw materials and supplies; resource constraints, including human capital and manufacturing capacity, on the ability of Novavax to pursue planned regulatory pathways; challenges meeting contractual requirements under agreements with multiple commercial, governmental, and other entities; and those other risk factors identified in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Novavax' Annual Report on Form 10-K for the year ended December 31, 2020 and subsequent Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission (SEC). We caution investors not to place considerable reliance on forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at
                          <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=2144051270&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3418278-1%26h%3D306882685%26u%3Dhttp%253A%252F%252Fwww.sec.gov%252F%26a%3Dwww.sec.gov&amp;a=www.sec.gov" rel="nofollow" target="_blank">
                           www.sec.gov
                          </a>
                          and
                          <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=3428978-1&amp;h=2094473873&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3418278-1%26h%3D393278701%26u%3Dhttp%253A%252F%252Fwww.novavax.com%252F%26a%3Dwww.novavax.com&amp;a=www.novavax.com" rel="nofollow" target="_blank">
                           www.novavax.com
                          </a>
                          , for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of the statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.
                         </p>
                         <p>
                          <b>
                           Contacts:
                          </b>
                         </p>
                         <p>
                          <u>
                           Investors
                           <br/>
                          </u>
                          Novavax, Inc.
                          <br/>
                          <span class="xn-person">
                           Erika Schultz
                          </span>
                          | 240-268-2022
                          <br/>
                          <a href="/cdn-cgi/l/email-protection#6c051e2c02031a0d1a0d14420f0301" rel="nofollow" target="_blank">
                           <span class="__cf_email__" data-cfemail="147d66547a7b627562756c3a777b79">
                            [email protected]
                           </span>
                          </a>
                         </p>
                         <p>
                          Solebury Trout
                          <br/>
                          <span class="xn-person">
                           Alexandra Roy
                          </span>
                          | 617-221-9197
                          <br/>
                          <a href="/cdn-cgi/l/email-protection#5534273a2c15263a39303720272c21273a20217b363a38" rel="nofollow" target="_blank">
                           <span class="__cf_email__" data-cfemail="dbbaa9b4a29ba8b4b7beb9aea9a2afa9b4aeaff5b8b4b6">
                            [email protected]
                           </span>
                          </a>
                         </p>
                         <p>
                          <u>
                           Media
                           <br/>
                          </u>
                          <span class="xn-person">
                           Ali Chartan
                          </span>
                          | 240-720-7804
                          <br/>
                          <span class="xn-person">
                           Laura Keenan Lindsey
                          </span>
                          | 202-709-7521
                          <br/>
                          <a href="/cdn-cgi/l/email-protection#f59890919c94b59b9a839483948ddb969a98" rel="nofollow" target="_blank">
                           <span class="__cf_email__" data-cfemail="117c74757870517f7e67706770693f727e7c">
                            [email protected]
                           </span>
                          </a>
                         </p>
                         <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1551">
                          <p>
                           <a href="https://mma.prnewswire.com/media/1506866/Novavax_High_Res_Logo.html" rel="nofollow" target="_blank">
                            <img alt="Novavax Logo (PRNewsfoto/Novavax)" src="https://mma.prnewswire.com/media/1506866/Novavax_High_Res_Logo.jpg" title="Novavax Logo (PRNewsfoto/Novavax)"/>
                           </a>
                          </p>
                         </div>
                         <p>
                         </p>
                         <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder0">
                         </div>
                         <p>
                          SOURCE  Novavax, Inc.
                         </p>
                         <img alt="" src="https://rt.prnewswire.com/rt.gif?NewsItemId=PH47280&amp;Transmission_Id=202201311342PR_NEWS_USPR_____PH47280&amp;DateId=20220131" style="border:0px; width:1px; height:1px;"/>
                        </div>
                       </div>
                       <div class="mc-socialShare act-component -sizeSmall">
                        <div class="mc-socialShare__rgnInner act-component-inner">
                         <div class="mc-socialShare__rgnMain">
                          <div class="mc-socialShare__print shareButton jsPrint">
                           <a aria-label="Print" class="af-link" href="#">
                            <i class="fas fa-print">
                            </i>
                           </a>
                          </div>
                          <div class="mc-socialShare__email shareButton jsEmail">
                           <a aria-label="Email" class="af-link" data-title="Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine" href="#">
                            <i class="fas fa-envelope">
                            </i>
                           </a>
                          </div>
                          <div class="mc-socialShare__rss shareButton jsRss">
                           <a aria-label="RSS" class="af-link" href="/press-releases/rss-feed" target="_blank">
                            <i class="fas fa-rss">
                            </i>
                           </a>
                          </div>
                          <div class="mc-socialShare__pdf shareButton jsPdf">
                           <a aria-label="Download PDF" class="af-link" href="/press-releases/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine?asPDF=1">
                            <i class="fas fa-file-pdf">
                            </i>
                           </a>
                          </div>
                          <div class="mc-socialShare__a2aButtons">
                           <div class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="#FFFFFF" data-a2a-url="#">
                            <a class="a2a_button_facebook">
                            </a>
                            <a class="a2a_button_twitter">
                            </a>
                            <a class="a2a_button_linkedin">
                            </a>
                            <a class="a2a_button_pinterest">
                            </a>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
              </div>
             </div>
             <div class="act-layout act-pane layout layout--bs-columns layout--footer-section -rgnWidth100">
              <div class="section-inner">
               <div class="act-pane__content row">
                <div class="act-pane__region layout__region layout__region--col-1 col-lg-12 col-md-12 col-sm-12">
                 <div class="oc-footer act-component jsPopupContainer">
                  <div class="oc-footer__rgnInner act-component-inner">
                   <div class="oc-footer__rgnTop">
                    <div class="oc-footer__rgnLogo">
                     <a href="https://www.novavax.com">
                      <div class="oc-footer__logo">
                       <img alt="Novavax. Creating tomorrow's vaccines today." class="af-image" src="/sites/default/files/images/novavax-footer-logo.svg"/>
                      </div>
                     </a>
                    </div>
                    <div aria-label="Secondary" class="oc-footer__rgnMain row" role="navigation">
                     <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                      <div class="oc-footer__sectionIcon">
                       <img alt="" class="af-image" src="/sites/default/files/images/Icon_Science_Technology_1.svg"/>
                      </div>
                      <h2 class="oc-footer__sectionTitle">
                       <div class="af-text">
                        Science &amp; technology
                       </div>
                      </h2>
                      <ul class="oc-footer__sectionNav">
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Overview" class="af-link" href="https://www.novavax.com/science-technology">
                          Overview
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Our pipeline" class="af-link" href="https://www.novavax.com/science-technology/vaccine-pipeline">
                          Our pipeline
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Recombinant nanoparticle vaccine technology" class="af-link" href="https://www.novavax.com/science-technology/recombinant-protein-based-nanoparticle-vaccine-technology">
                          Recombinant nanoparticle vaccine technology
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Matrix-M™ adjuvant technology" class="af-link" href="https://www.novavax.com/science-technology/matrix-m-adjuvant-technology">
                          Matrix-M™ adjuvant technology
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Global vaccine approval/authorization map" class="af-link" href="https://www.novavax.com/global-vaccine-approval-authorization-map">
                          Global vaccine approval/authorization map
                         </a>
                        </div>
                       </li>
                      </ul>
                     </div>
                     <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                      <div class="oc-footer__sectionIcon">
                       <img alt="" class="af-image" src="/sites/default/files/images/Icon_Who_We_Are_0.svg"/>
                      </div>
                      <h2 class="oc-footer__sectionTitle">
                       <div class="af-text">
                        Who we are
                       </div>
                      </h2>
                      <ul class="oc-footer__sectionNav">
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Our company" class="af-link" href="https://www.novavax.com/who-we-are">
                          Our company
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Executive leadership" class="af-link" href="https://www.novavax.com/who-we-are/leadership#executive-leadership">
                          Executive leadership
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Board of directors" class="af-link" href="https://www.novavax.com/who-we-are/leadership#board-of-directors">
                          Board of directors
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Our partners" class="af-link" href="https://www.novavax.com/who-we-are/partners">
                          Our partners
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Our commitments" class="af-link" href="https://www.novavax.com/who-we-are/our-commitments">
                          Our commitments
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Our transparency commitment" class="af-link" href="https://www.novavax.com/who-we-are/global-disclosure-statement">
                          Our transparency commitment
                         </a>
                        </div>
                       </li>
                      </ul>
                     </div>
                     <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                      <div class="oc-footer__sectionIcon">
                       <img alt="" class="af-image" src="/sites/default/files/images/Icon_More_Information_0.svg"/>
                      </div>
                      <h2 class="oc-footer__sectionTitle">
                       <div class="af-text">
                        More information
                       </div>
                      </h2>
                      <ul class="oc-footer__sectionNav">
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)" class="af-link" href="https://www.novavaxcovidvaccine.com">
                          Global authorization site of Novavax COVID-19 Vaccine (recombinant, adjuvanted)
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Global medical information site" class="af-link" href="https://www.novavaxmedinfo.com">
                          Global medical information site
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Ask medical or scientific questions about our product, report adverse events, and product quality complaints" class="af-link" href="https://www.novavaxmedinfo.com">
                          Ask medical or scientific questions about our product, report adverse events, and product quality complaints
                         </a>
                        </div>
                       </li>
                      </ul>
                     </div>
                     <div class="oc-footer__rgnSection col-lg-2 col-md-4 col-sm-12">
                      <div class="oc-footer__sectionIcon">
                       <img alt="" class="af-image" src="/sites/default/files/images/Icon_Contact_Us_0.svg"/>
                      </div>
                      <h2 class="oc-footer__sectionTitle">
                       <div class="af-text">
                        Contact us
                       </div>
                      </h2>
                      <ul class="oc-footer__sectionNav">
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Connect with us" class="af-link" href="https://www.novavax.com/node/361">
                          Connect with us
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Sign up for updates" class="af-link" href="https://ir.novavax.com/join-press-release-list">
                          Sign up for updates
                         </a>
                        </div>
                       </li>
                       <li class="oc-footer__navItem">
                        <div class="oc-footer__navLink">
                         <a aria-label="Social media guidelines" class="af-link" href="https://www.novavax.com/social-media-community-guidelines">
                          Social media guidelines
                         </a>
                        </div>
                       </li>
                      </ul>
                      <ul class="oc-footer__rgnSocial">
                       <li class="oc-footer__socialLink">
                        <a aria-label="Linkedin" class="af-link" href="https://www.linkedin.com/company/novavax/?utm_source=website_homepage&amp;utm_medium=clicks&amp;utm_id=footer_link">
                         <i class="fab fa-linkedin-in">
                         </i>
                        </a>
                       </li>
                       <li class="oc-footer__socialLink">
                        <a aria-label="Twitter" class="af-link" href="https://twitter.com/Novavax?utm_source=website_homepage&amp;utm_medium=clicks&amp;utm_id=footer_link">
                         <i class="fab fa-twitter">
                         </i>
                        </a>
                       </li>
                       <li class="oc-footer__socialLink">
                        <a aria-label="YouTube" class="af-link" href="https://www.youtube.com/c/Novavax?utm_source=website_homepage&amp;utm_medium=clicks&amp;utm_id=footer_link">
                         <i class="fab fa-youtube">
                         </i>
                        </a>
                       </li>
                       <li class="oc-footer__socialLink">
                        <a aria-label="Facebook" class="af-link" href="https://www.facebook.com/Novavax/?utm_source=website_homepage&amp;utm_medium=clicks&amp;utm_id=footer_link">
                         <i class="fab fa-facebook-f">
                         </i>
                        </a>
                       </li>
                      </ul>
                     </div>
                     <div class="oc-footer__rgnSection col-lg-3 col-md-4 col-sm-12">
                      <div class="oc-footer__sectionIcon">
                       <img alt="" class="af-image" src="/sites/default/files/images/Icon_Careers_0.svg"/>
                      </div>
                      <h2 class="oc-footer__sectionTitle">
                       <div class="af-text">
                        Careers
                       </div>
                      </h2>
                      <div class="oc-footer__sectionDesc">
                       <div class="af-text">
                        <p>
                         <span class="s-circle">
                          44
                         </span>
                         <a href="/careers">
                          Current opportunities
                         </a>
                        </p>
                        <p>
                         Novavax is proud to be recognized by the 2021 Top Workplaces USA, reflecting our dedication to an exceptional work culture
                        </p>
                        <p>
                         Explore current opportunities in:
                        </p>
                       </div>
                      </div>
                      <ul class="oc-footer__rgnFlags">
                       <li class="oc-footer__flagItem">
                        <a aria-label="Career opportunities in USA" href="https://www.novavax.com/careers/jobs?keywords=&amp;country=USA%20&amp;loc_id=&amp;cat_id=" target="_blank">
                         <div class="oc-footer__flagIcon">
                          <img alt="USA flag" class="af-image" src="/act-root/novavax/assets/icons/flags/us.svg"/>
                         </div>
                         <div class="oc-footer__flagTitle">
                          <div class="af-text">
                           USA
                          </div>
                         </div>
                        </a>
                       </li>
                       <li class="oc-footer__flagItem">
                        <a aria-label="Career opportunities in CZ" href="https://www.novavax.cz/en/career/" target="_blank">
                         <div class="oc-footer__flagIcon">
                          <img alt="CZ flag" class="af-image" src="/act-root/novavax/assets/icons/flags/cz.svg"/>
                         </div>
                         <div class="oc-footer__flagTitle">
                          <div class="af-text">
                           CZ
                          </div>
                         </div>
                        </a>
                       </li>
                       <li class="oc-footer__flagItem">
                        <a aria-label="Career opportunities in SE" href="https://www.novavax.se/karriärer" target="_blank">
                         <div class="oc-footer__flagIcon">
                          <img alt="SE flag" class="af-image" src="/act-root/novavax/assets/icons/flags/se.svg"/>
                         </div>
                         <div class="oc-footer__flagTitle">
                          <div class="af-text">
                           SE
                          </div>
                         </div>
                        </a>
                       </li>
                       <li class="oc-footer__flagItem">
                        <a aria-label="Career opportunities in EUR" href="https://www.novavax.com/careers/jobs?keywords=&amp;country=AUT%20DEU%20ITA%20POL%20ESP%20CHE%20GBR%20&amp;loc_id=&amp;cat_id=" target="_blank">
                         <div class="oc-footer__flagIcon">
                          <img alt="EUR flag" class="af-image" src="/act-root/novavax/assets/icons/flags/eu.svg"/>
                         </div>
                         <div class="oc-footer__flagTitle">
                          <div class="af-text">
                           EUR
                          </div>
                         </div>
                        </a>
                       </li>
                       <li class="oc-footer__flagItem">
                        <a aria-label="Career opportunities in APAC" href="https://www.novavax.com/careers/jobs?keywords=&amp;country=SGP%20&amp;loc_id=&amp;cat_id=" target="_blank">
                         <div class="oc-footer__flagIcon">
                          <img alt="APAC flag" class="af-image" src="/act-root/novavax/assets/icons/flags/apac.svg"/>
                         </div>
                         <div class="oc-footer__flagTitle">
                          <div class="af-text">
                           APAC
                          </div>
                         </div>
                        </a>
                       </li>
                      </ul>
                     </div>
                     <div class="oc-footer__sideImage col-lg-1 col-md-4 col-sm-12">
                      <img alt="TOP WORK PLACES 2021. USA. TOP WORKPLACE FOR 2021 By Energage" class="af-image" src="/sites/default/files/images/top-workplace.png"/>
                     </div>
                    </div>
                   </div>
                   <div class="oc-footer__rgnBottom d-block">
                    <div class="oc-footer__rgnBottomInner">
                     <div class="oc-footer__copyright">
                      <div class="af-text">
                       © 2023 Novavax. All rights reserved.
                      </div>
                     </div>
                     <ul class="oc-footer__rgnBottomNav">
                      <li class="oc-footer__bottomItem">
                       <div class="oc-footer__bottomLink">
                        <a aria-label="Privacy policy" class="af-link" href="https://www.novavax.com/node/151">
                         Privacy policy
                        </a>
                       </div>
                      </li>
                      <li class="oc-footer__bottomItem">
                       <div class="oc-footer__bottomLink">
                        <a aria-label="Cookies policy" class="af-link" href="https://www.novavax.com/node/236">
                         Cookies policy
                        </a>
                       </div>
                      </li>
                      <li class="oc-footer__bottomItem">
                       <div class="oc-footer__bottomLink">
                        <a aria-label="Terms and conditions" class="af-link" href="https://www.novavax.com/node/231">
                         Terms and conditions
                        </a>
                       </div>
                      </li>
                      <li class="oc-footer__bottomItem">
                       <div class="oc-footer__bottomLink">
                        <a aria-label="Site map" class="af-link" href="/sitemap">
                         Site map
                        </a>
                       </div>
                      </li>
                      <li class="oc-footer__bottomItem">
                       <div class="oc-footer__bottomLink">
                        <a aria-label="Pay Transparency Nondiscrimination Provision" class="af-link" href="https://novavax.widen.net/s/r28zg5tbjw/ofccp_pay_transparency_nondiscrimination_provision">
                         Pay Transparency Nondiscrimination Provision
                        </a>
                       </div>
                      </li>
                      <li class="oc-footer__bottomItem">
                       <div class="oc-footer__bottomLink">
                        <a aria-label="Purchase Order Terms and Conditions" class="af-link" href="https://www.novavax.com/PO-terms-and-conditions">
                         Purchase Order Terms and Conditions
                        </a>
                       </div>
                      </li>
                     </ul>
                    </div>
                   </div>
                  </div>
                  <!-- Modal -->
                  <div aria-hidden="true" class="modal fade media-lightbox -redirect jsExtRedirect" id="fBUs05" role="dialog" tabindex="-1">
                   <div class="modal-dialog modal-dialog-centered" role="document">
                    <div class="modal-content jsModalContent">
                     <div class="modal-header">
                      <button aria-label="Close" class="close" data-dismiss="modal" type="button">
                       <span aria-hidden="true">
                        <i class="fal fa-times">
                        </i>
                       </span>
                      </button>
                     </div>
                     <div class="modal-body">
                      <div class="modal-body__title">
                       <div class="af-text">
                        You are leaving novavax.com
                       </div>
                      </div>
                      <div class="modal-body__summary">
                       <div class="af-text">
                        <p>
                         You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Novavax provides this link as a service to website visitors. Novavax is not responsible for the privacy policy of any third-party websites.
                        </p>
                       </div>
                      </div>
                      <div class="modal-body__rgnActions">
                       <div class="modal-body__actionButton">
                        <a class="jsPopRedirect" href="#">
                         Continue
                        </a>
                       </div>
                       <div class="modal-body__actionButton">
                        <a class="jsPopCancel" href="#">
                         Cancel
                        </a>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                  <!-- Modal -->
                  <div aria-hidden="true" class="modal fade media-lightbox -redirect jsMedicalRedirect" id="fpPk0n" role="dialog" tabindex="-1">
                   <div class="modal-dialog modal-dialog-centered" role="document">
                    <div class="modal-content jsModalContent">
                     <div class="modal-header">
                      <button aria-label="Close" class="close" data-dismiss="modal" type="button">
                       <span aria-hidden="true">
                        <i class="fal fa-times">
                        </i>
                       </span>
                      </button>
                     </div>
                     <div class="modal-body">
                      <div class="modal-body__title">
                       <div class="af-text">
                        This Novavax website is for medical professionals only.
                       </div>
                      </div>
                      <div class="modal-body__summary">
                       <div class="af-text">
                        <p>
                         Click "Continue" only if you are a medical professional.
                        </p>
                       </div>
                      </div>
                      <div class="modal-body__rgnActions">
                       <div class="modal-body__actionButton">
                        <a class="jsPopRedirect" href="#">
                         Continue
                        </a>
                       </div>
                       <div class="modal-body__actionButton">
                        <a class="jsPopCancel" href="#">
                         Cancel
                        </a>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                  <!-- Modal -->
                  <div aria-hidden="true" class="modal fade media-lightbox -redirect jsIISRedirect" id="fVhf6I" role="dialog" tabindex="-1">
                   <div class="modal-dialog modal-dialog-centered" role="document">
                    <div class="modal-content jsModalContent">
                     <div class="modal-header">
                      <button aria-label="Close" class="close" data-dismiss="modal" type="button">
                       <span aria-hidden="true">
                        <i class="fal fa-times">
                        </i>
                       </span>
                      </button>
                     </div>
                     <div class="modal-body">
                      <div class="modal-body__title">
                       <div class="af-text">
                        You are leaving novavax.com
                       </div>
                      </div>
                      <div class="modal-body__summary">
                       <div class="af-text">
                        <p>
                         You have selected a link that will take you to a site maintained by a third party. Novavax is not responsible for the Privacy Policy of any third-party websites.
                        </p>
                       </div>
                      </div>
                      <div class="modal-body__rgnActions">
                       <div class="modal-body__actionButton">
                        <a class="jsPopRedirect" href="#">
                         Continue
                        </a>
                       </div>
                       <div class="modal-body__actionButton">
                        <a class="jsPopCancel" href="#">
                         Cancel
                        </a>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                  <!-- Modal -->
                  <div aria-hidden="true" class="modal fade media-lightbox -redirect jsCountryDisclaimer" id="pL7aKL" role="dialog" tabindex="-1">
                   <div class="modal-dialog modal-dialog-centered" role="document">
                    <div class="modal-content jsModalContent">
                     <div class="modal-header">
                      <button aria-label="Close" class="close" data-dismiss="modal" type="button">
                       <span aria-hidden="true">
                        <i class="fal fa-times">
                        </i>
                       </span>
                      </button>
                     </div>
                     <div class="modal-body">
                      <div class="modal-body__title">
                       <div class="af-text">
                        DISCLAIMER:
                       </div>
                      </div>
                      <div class="modal-body__summary">
                       <div class="af-text">
                        <p>
                         The information provided on this website is intended for members of the general public in
                         <span class="jsTargetCountry">
                         </span>
                         only.
                        </p>
                       </div>
                      </div>
                      <div class="modal-body__rgnActions">
                       <div class="modal-body__actionButton">
                        <a class="jsPopRedirect" href="#">
                         Continue
                        </a>
                       </div>
                       <div class="modal-body__actionButton">
                        <a class="jsPopCancel" href="#">
                         Cancel
                        </a>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
              </div>
             </div>
            </div>
           </div>
          </div>
         </section>
        </main>
       </div>
      </div>
     </div>
    </div>
   </div>
  </div>
  <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js">
  </script>
  <script data-drupal-selector="drupal-settings-json" type="application/json">
   {"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"press-releases\/2022-01-31-Novavax-Submits-Request-to-the-U-S-FDA-for-Emergency-Use-Authorization-of-COVID-19-Vaccine","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en","currentQuery":{"sf159335945":"1"}},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"ajaxPageState":{"libraries":"act_bootstrap\/base,act_bootstrap\/theme,act_layout\/layout_bootstrap,act_layout\/off_canvas_override,bootstrap_barrio\/global-styling,eu_cookie_compliance\/eu_cookie_compliance_default,extlink\/drupal.extlink,nvaxcom_bootstrap\/nvaxcom-app,system\/base","theme":"nvaxcom_bootstrap","theme_token":null},"ajaxTrustedUrl":[],"data":{"extlink":{"extTarget":true,"extTargetNoOverride":false,"extNofollow":false,"extNoreferrer":false,"extFollowNoOverride":false,"extClass":"0","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":"","extInclude":"","extCssExclude":"","extCssExplicit":"","extAlert":false,"extAlertText":"This link will take you to an external web site. We are not responsible for their content.","mailtoClass":"0","mailtoLabel":"(link sends email)","extUseFontAwesome":false,"extIconPlacement":"append","extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","whitelistedDomains":null}},"eu_cookie_compliance":{"cookie_policy_version":"1.0.0","popup_enabled":false,"popup_agreed_enabled":false,"popup_hide_agreed":false,"popup_clicking_confirmation":true,"popup_scrolling_confirmation":false,"popup_html_info":false,"use_mobile_message":false,"mobile_popup_html_info":false,"mobile_breakpoint":768,"popup_html_agreed":false,"popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/","popup_link_new_window":true,"popup_position":false,"fixed_top_position":true,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":false,"cookie_name":"","reload_page":false,"domain":"","domain_all_sites":false,"popup_eu_only":false,"popup_eu_only_js":false,"cookie_lifetime":100,"cookie_session":0,"set_cookie_session_zero_on_disagree":0,"disagree_do_not_show_popup":false,"method":"default","automatic_cookies_removal":true,"allowed_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv aria-labelledby=\u0022popup-text\u0022 class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info eu-cookie-compliance-content\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022 class=\u0022eu-cookie-compliance-message\u0022 role=\u0022document\u0022\u003E\n      \u003Ch2\u003EWe use cookies on this site to enhance your user experience\u003C\/h2\u003E\u003Cp\u003EYou have given your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022 class=\u0022eu-cookie-compliance-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button \u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","withdraw_enabled":false,"reload_options":0,"reload_routes_list":"","withdraw_button_on_info_popup":false,"cookie_categories":[],"cookie_categories_details":[],"enable_save_preferences_button":true,"cookie_value_disagreed":"0","cookie_value_agreed_show_thank_you":"1","cookie_value_agreed":"2","containing_element":"body","settings_tab_enabled":false,"olivero_primary_button_classes":"","olivero_secondary_button_classes":"","close_button_action":"","open_by_default":false,"modules_allow_popup":true,"hide_the_banner":false,"geoip_match":true},"user":{"uid":0,"permissionsHash":"0f5fe3ed6280a55dd25e7d616dd833596b1af8798d00d1645ed40d5684a215fe"}}
  </script>
  <script src="/sites/default/files/js/js_E57fX--ImowTXMFz_iRAts8_7XUVMWsYuVGIiw_Heqc.js">
  </script>
  <script src="https://api.mapbox.com/mapbox-gl-js/v2.6.1/mapbox-gl.js">
  </script>
  <script async="" src="https://static.addtoany.com/menu/page.js">
  </script>
  <script src="/sites/default/files/js/js_51hhOqIpoBcRsEp23mX6shqoSvZ-yIi6dG3c1AMazMY.js">
  </script>
  <script defer="" src="/modules/contrib/eu_cookie_compliance/js/eu_cookie_compliance.min.js?v=9.5.7">
  </script>
  <!-- Insight Tag  -->
  <script type="text/javascript">
   _linkedin_partner_id = "3958308";
window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || [];
window._linkedin_data_partner_ids.push(_linkedin_partner_id);
  </script>
  <script type="text/javascript">
   (function(l) {
if (!l){window.lintrk = function(a,b){window.lintrk.q.push([a,b])};
window.lintrk.q=[]}
var s = document.getElementsByTagName("script")[0];
var b = document.createElement("script");
b.type = "text/javascript";b.async = true;
b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js";
s.parentNode.insertBefore(b, s);})(window.lintrk);
  </script>
  <noscript>
   <img alt="" height="1" src="https://px.ads.linkedin.com/collect/?pid=3958308&amp;fmt=gif" style="display:none;" width="1">
   </img>
  </noscript>
  <!-- End Insight Tag -->
  <script type="text/javascript">
   window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"NRJS-791f154b50ffd458658","applicationID":"586088839","transactionName":"NFIEZkoEDUNWVE1ZDA0YJ1FMDAxeGHNLRRMCWzpcTgQbU1haZlETE2slXVYREV9bW1xCPzNFA0FLJgxeQ0VWXA8GRUsMSgANVFJFfVUXAl4KYlkCBg==","queueTime":4,"applicationTime":1464,"atts":"GBUHEAIeHk0=","errorBeacon":"bam.nr-data.net","agent":""}
  </script>
 </body>
</html>
